METTL14 and ovarian carcinoma: Because the loss of WTAP significantly blocks the m6A RNA modification process, we knocked down WTAP with siRNA in METTL14-overexpressing cells (Figures 6G, H) to evaluate the effects on ovarian cancer cell proliferation.